The latest forecasts suggest that weekly hospitalization rates will continue to rise, most likely to double what they are now by the season's peak in December.
Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are meeting on Friday to discuss recommendations for use of the first vaccine for respiratory syncytial virus (RSV) approved for pregnant women to protect their babies. That Pfizer shot and one developed by GSK in May became the first two RSV vaccines to win U.S. approval, for use in people aged 60 and over to prevent severe illness.
Advisers to the U.S. Centers for
Disease Control and Prevention are meeting on Friday to
discuss recommendations for use of the first vaccine for
respiratory syncytial virus approved for pregnant.
Explainer: What you need to know about RSV and the new vaccines reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.